Filter by: patients
Home > Community Treatment Reports and Side Effects > Fragmin Treatment Report
What is Fragmin?

Fragmin® is a brand name for dalteparin, a low molecular weight heparin used for the prevention of deep vein thrombosis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Prevent blood clotting 3 0
Causes blood to thin 1 1 Efficacy_major
Blood Clot 1 1 Efficacy_major
Stroke prophylatic 1 0
MS (Multiple Sclerosis) 1 1 Efficacy_none

See all 4 patients currently taking Fragmin

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 0
None
 1

Reported Dosages

  7,500IU as needed 2,500 intl units/0.2 mL daily 2 x 5,000 intl units/0.2 mL daily 12,500 intl units/0.5 mL daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Fragmin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2   Doctor's advice: 67%
Course of treatment ended 1   Course of treatment ended: 33%

See all 3 patients who’ve stopped taking Fragmin

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Fragmin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Fragmin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Fragmin

Always
 2 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Fragmin

Very
 1 50%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 50%

Cost

Paid out of pocket

Cost of Fragmin

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.